Harte-Hanks, Inc. (HHS) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $2.77 +10.36%
Financial Fact:
Operating income: -4.57M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Operating income: -4.57M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Harte-Hanks, Inc. (NYSE: HHS) reported Q2 EPS of $0.13, in-line with the analyst estimate of $0.13. Revenue for the quarter came in at $199.1 million versus the consensus estimate of $199.93 million.
For earnings history and earnings-related data on Harte-Hanks, Inc. (HHS) click here.
For earnings history and earnings-related data on Harte-Hanks, Inc. (HHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
- PSQ Holdings closes $1.3M private placement with board participation
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
